Quick Answer
Milestone Pharmaceuticals Inc. reported Total Assets of $113.56 million for fiscal year 2025.
Milestone Pharmaceuticals Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $113.56M | +50.4% |
| 2024 | $75.50M | +0.4% |
| 2023 | $75.23M | +1.0% |
| 2022 | $74.48M | -37.9% |
| 2021 | $119.85M | -20.1% |
| 2020 | $149.97M | +21.5% |
| 2019 | $123.43M | +40.1% |
| 2018 | $88.08M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $87.75M | +6.1% | +85.1% |
| June 30, 2025 | $47.42M | -46.9% | -23.4% |
| March 31, 2025 | $61.88M | -35.5% | -18.0% |
| December 31, 2024 | $75.50M | +0.4% | -8.7% |
| September 30, 2024 | $82.71M | -5.1% | -7.3% |
| June 30, 2024 | $89.23M | -8.0% | -7.1% |
| March 31, 2024 | $96.00M | -13.6% | +27.6% |
| December 31, 2023 | $75.23M | +1.0% | -13.6% |
- Milestone Pharmaceuticals Inc. showed an increase of +50.4% in Total Assets compared to the prior fiscal year.
- Over the 2018–2025 period, Milestone Pharmaceuticals Inc.’s total assets has grown by 28.9% (from $88.08 million to $113.56 million).
- The most recent figure is from Milestone Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: